SHELLI ADAM: Open Payments
NPI 1235262866 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,623 in 163 payments from 19 companies in 2025. Trend: 2023 $771 · 2024 $3,253 · 2025 $3,623
Food & beverage: $3,546Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $541 |
| Janssen Biotech, Inc. | 15 | $465 |
| Madrigal Pharmaceuticals | 10 | $421 |
| Aimmune Therapeutics, Inc. | 29 | $330 |
| Ardelyx, Inc. | 15 | $262 |
| QOL Medical, LLC | 8 | $213 |
| Amgen Inc. | 5 | $191 |
| Gilead Sciences, Inc. | 7 | $182 |
| Lilly USA, LLC | 9 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
Products named: TREMFYA, REZDIFFRA, VOWST, IBSRELA, Sucraid, OMVOH, RINVOQ, ENTYVIO.
Industry payments across FL — which companies pay providers there.
